- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Investment Research Partners LLC Acquires 10,212 Shares in Johnson & Johnson
The institutional investor now holds a 0.9% stake in the healthcare giant.
Mar. 21, 2026 at 9:04am
Got story updates? Submit your updates here. ›
Investment Research Partners LLC, an institutional investor, has purchased a new position in shares of Johnson & Johnson (NYSE:JNJ) in the 3rd quarter. The firm acquired 10,212 shares of the company's stock, valued at approximately $1,906,000, making Johnson & Johnson the 20th largest holding in its investment portfolio.
Why it matters
This transaction highlights the continued institutional interest and confidence in Johnson & Johnson, one of the world's largest and most diversified healthcare companies. As a major player in pharmaceuticals, medical devices, and consumer health, Johnson & Johnson's stock is closely watched by investors seeking exposure to the healthcare sector.
The details
According to the company's most recent disclosure with the Securities and Exchange Commission (SEC), Investment Research Partners LLC purchased the 10,212 shares of Johnson & Johnson in the 3rd quarter. This new position represents 0.9% of the firm's total investment portfolio.
- The transaction occurred in the 3rd quarter of the year.
The players
Investment Research Partners LLC
An institutional investor that has now acquired a 0.9% stake in Johnson & Johnson.
Johnson & Johnson
A multinational healthcare company that develops, manufactures, and markets a broad range of pharmaceutical, medical device, and consumer health products.
The takeaway
This investment by Investment Research Partners LLC underscores the continued appeal of Johnson & Johnson as a stable, diversified healthcare company with a strong track record. The transaction reflects the institutional investor's confidence in Johnson & Johnson's ability to generate long-term returns for its shareholders.
